Inhibition of tumour growth by lipoxygenase inhibitors

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 683-687

  Hussey, H J ^a   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Arachidonic acid; Colon cancer; Hydroxyeicosatetraenoic acid; Linoleic acid; Lipoxygenase inhibition

Indexed keywords

ARACHIDIC ACID; HYDROXYICOSATETRAENOIC ACID; LIPOXYGENASE INHIBITOR; N [3 (3 PHENOXYPHENYL)ALLYL]ACETOHYDROXAMIC ACID; ZILEUTON;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029740056     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.422     Document Type: Article

References (17)

1. 2. J. Biol. Chem., 263, 7567-7573.
2. CARTER GW, YOUNG PR, ALBERT DH. BOUSAKA J, DYER R, BELL RL, SUMMER JB AND BROOKS DW. (1991). 5-Lipoxygenase inhibitory activity of Zileuton. J. Pharmacol. Exp. Ther., 256, 929-937.
3. GLASGOW WC AND ELING TE. (1990). Epidermal growth factor stimulates linoleic acid metabolism in Balb/c 3T3 fibroblasts. Mol. Pharmacol., 38, 503-510.
4. GRIDLEY G, MCLAUGHLIN JK, EKBOM A, KLARESKOG L, ADAMI H-O, HACKER DG, HOOVER R AND FRAUMENI JF. (1993). Incidence of cancer among patients with rheumatoid arthritis. J. Natl Cancer Inst., 85, 307-311.
5. HOPKINS GJ AND CARROLL KK. (1979). Relationship between amount and type of dietary fat in promotion of mammary carcinogenesis induced by 7,12-dimethylbenz [a] anthracene. J. Natl Cancer Inst., 62, 1009-1012.
6. HUSSEY HJ AND TISDALE MJ. (1994). Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo. Br. J. Cancer, 70, 6-10.
7. IP C, CARTER CA AND IP MM. (1985). Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res., 45, 1997-2001.
8. KARMALI RA. (1987). Fatty acids: inhibition. Am. J. Clin. Nutr., 45, 225-229.
9. LIU B, MARNETT LJ, CHAUDHARY A, JI C, BLAIR IA, JOHNSON CR, DIGLIO CA AND HONN KV. (1994). Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab. Invest., 70, 314-323.
10. MCMILLAN RM AND WALKER ERH. (1992). Designing therapeutically effective 5-lipoxygenase inhibitors. TiPs, 13, 323-330.
11. MARNETT LJ. (1992). Asprin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
12. PRITCHARD GA, JONES DL AND MANSEL RE. (1989). Lipids in breast carcinogenesis. Br. J. Surg., 76, 1069-1073.
13. REPORT OF THE BRITISH NUTRITION FOUNDATION'S TASK FORCE. (1992). Unsaturated Fatty Acids, pp. 152-163. Chapman and Hall: London.
14. SALMON JA AND GARLAND LG. (1991). Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents. Prog. Drug Res., 37, 1-90.
15. 3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. Cancer Res., 48, 3106-3111.
16. SETTY BNY, GRAEBER JE AND STUART MJ. (1987). The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acids on endothelial cells may be mediated via diacylglycerol kinase inhibition. J. Biol. Chem., 262, 17613-17622.
17. TATESON JE, RANDALL RW, REYNOLDS CH, JACKSON WP, BHATTACHEJEE P, SALMON JA AND GARLAND LG. (1988). Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and in vivo. Br. J. Pharmacol., 94, 528-529.